Cross Icon

Press Releases

Your source for Evernorth news.

Cross Icon
Featured

Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year

  • Estimated to save individual Accredo patients around $4,000 per year
  • Biosimilar price will be more than 80% lower than Stelara list price
  • Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Read more
""

Filter Press Releases

Media contact:

media@evernorth.com
Press Release

Pharmacists’ Role to Expand Over Next Decade amid the Pandemic and Provider Shortages

Nearly 80% of patients see pharmacists as a key component of their health care team. To meet growing demand and fill gaps in care, more advanced training for pharmacists in areas such as chronic disea...

January 12, 22

Read More
Press Release

Behavioral Health Treatment Helps Reduce Total Cost of Care, New Evernorth Analysis Finds

First-of-its-kind analysis proves medical and pharmacy costs can decrease by more than $3,000 over two years when people receive outpatient behavioral health care.

November 16, 21

Read More
Press Release

Express Scripts Creates Industry-First Solution to Provide Coverage for At-Home COVID-19 Test Kits

New offering will help employers and health plans support their employ-ees’ wellbeing with expanded, affordable access to testing options under their pharmacy benefit

November 10, 21

Read More
Press Release

State of West Virginia Selects Express Scripts to Bring Affordability to PEIA Pharmacy Benefit Program

Three-Year Agreement Covers 165,000 State Employees

November 08, 21

Read More
Press Release

Express Scripts Will Unlock $20 Million in Savings for Clients in 2022 by Preferring the First Interchangeable Insulin Biosimilar

October 20, 21

Read More